On February 28, GoodRx Holdings Inc. (GDRX) declared its Q4 and fiscal 2021 financial results. Along with that, the company also announced a share repurchase program. Following the news, the company’s stock took a harsh hit in the after-hours as it missed both earnings and outlook estimates.
The stock remained bullish in the regular session on positive expectations of the earnings report as it traded at 4.07 million shares. At 251% of the average volume, GDRX stock closed the session at $27.40, to gain a value of 4.22%. Following the announcements, the stock took a blow in the after-hours to reach $19.37. Hence, the stock lost a huge 29.31% in the after-hours while 2.15 million shares exchanged hands. Therefore, the missed earnings caused the stock to mark its new 52-week low in the after-hours against the previous $21.13.
The consumer-focused digital healthcare platform operator, GoodRx Holdings Inc. was founded in 2015. The Santa Monica, CA-based company has a market capitalization of $10.49 billion with its 80.7 million outstanding shares. Currently, the stock stands at a year-to-date loss of 16.16% while it has added 8.13% in the past five days.
GDRX’s 2021 Financials
Q4 2021
In the fourth quarter of 2021, the company’s revenue increased by 39% YOY to $213.3 million.
Moreover, the adjusted net income of GDRX was $40.5 million in Q4 2021, against $32.2 million in the year-ago quarter. Thus, marking a YOY change of 26%.
The adjusted EBITDA margin went down by 280 bps TO 29.2% in the quarter, against 32.0% a year ago.
Fiscal 2021
The company had revenue of $745.4 million in fiscal 2021, marking an increase of 35% YOY.
Furthermore, the adjusted net income was $147.0 million with an increase of 10% YOY.
Additionally, the adjusted EBITDA margin declined u 610 bps to 30.8% in fiscal 2021.
2022 Outlook
GDRX expects an adjusted EBITDA margin of 28-30% on revenue of $200 million approx. for Q1 2022. For fiscal 2022, the company expects an adjusted EBITDA margin of 31-33% with revenue growth of approx. 23% YOY.
Share Repurchase Program
The company also announced the authorization of up to $250 million of Class A common stock’s share repurchase program. The program is expected to expire on February 23, 2024, but can be modified, suspended, or terminated at the discretion of GDRX at any time.
